Atlas Trials

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

Clinical trial NCT05396807 · COMPLETED

Trial details

NCT number
NCT05396807
Sponsor
University of Rome Tor Vergata
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Colon Cancer
Start date
2023-03-21
Primary completion
2024-03-31
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.